These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26575306)

  • 21. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.
    Catena C; Colussi G; Di Fabio A; Valeri M; Marzano L; Uzzau A; Sechi LA
    Horm Metab Res; 2010 Jun; 42(6):440-5. PubMed ID: 20119883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
    Young WF
    Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of aldosteronism in causing obesity-related cardiovascular risk.
    Calhoun DA; Sharma K
    Cardiol Clin; 2010 Aug; 28(3):517-27. PubMed ID: 20621254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.
    Savard S; Amar L; Plouin PF; Steichen O
    Hypertension; 2013 Aug; 62(2):331-6. PubMed ID: 23753408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperaldosteronism as a common cause of resistant hypertension.
    Calhoun DA
    Annu Rev Med; 2013; 64():233-47. PubMed ID: 23092384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism.
    Rossi G; Rossi A; Zanin L; Calabró A; Crepaldi G; Pessina AC
    Am J Hypertens; 1993 Jan; 6(1):8-14. PubMed ID: 8427667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of primary aldosteronism.
    Mulatero P; Monticone S; Bertello C; Tizzani D; Iannaccone A; Crudo V; Veglio F
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):188-93. PubMed ID: 20389241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
    J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary aldosteronism.
    Fardella CE; Mosso L
    Clin Lab; 2002; 48(3-4):181-90. PubMed ID: 11934220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
    Baguet JP; Steichen O; Mounier-Véhier C; Gosse P
    Ann Endocrinol (Paris); 2016 Jul; 77(3):187-91. PubMed ID: 27087531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary aldosteronism.
    Carey RM
    Horm Res; 2009 Jan; 71 Suppl 1():8-12. PubMed ID: 19153497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary hyperaldosteronism: a diagnostic algorithm].
    Del Giudice A; Prencipe M; Aucella F
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China.
    Sang X; Jiang Y; Wang W; Yan L; Zhao J; Peng Y; Gu W; Chen G; Liu W; Ning G
    J Hypertens; 2013 Jul; 31(7):1465-71; discussion 1471-2. PubMed ID: 24006040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary hyperaldosteronism: common cause of secondary hypertension with higher cardiovascular risk].
    Widimský J
    Vnitr Lek; 2013 Jun; 59(6):501-4. PubMed ID: 23808747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.